Search

Your search keyword '"CHO CELLS"' showing total 48 results

Search Constraints

Start Over You searched for: Descriptor "CHO CELLS" Remove constraint Descriptor: "CHO CELLS" Publication Type Magazines Remove constraint Publication Type: Magazines
48 results on '"CHO CELLS"'

Search Results

2. Reports Outline Machine Learning Study Results from University of Padua (Productive Cho Cell Lines Selection In Biopharm Process Development Through Machine Learning On Metabolomic Dynamics).

3. Patent Issued for Manufacturing methods for producing anti-TNF antibody compositions (USPTO 12180271).

4. Patent Issued for Asparagine feed strategies to improve cell culture performance and mitigate asparagine sequence variants (USPTO 12163122).

5. Patent Issued for Anti-tumor necrosis factor (TNF) antibodies and compositions thereof (USPTO 12129292).

6. A Phase 1, Placebo-controlled, Randomized, Observer-blind Study to Describe the Safety, Reactogenicity and Immunogenicity of a Bivalent Recombinant Respiratory Syncytial Virus (RSV) Vaccine (CHO Cell) (SCB-1019T) in Children 2 to <6 Years of Age.

7. A Randomized, Double-blind Phase III Clinical Trial to Evaluate the Lot-to-lot Consistency of Three Consecutive Batches of Recombinant Herpes Zoster Vaccine (CHO Cell) Produced At a Commercial Scale in Subjects Aged 40 Years and Older.

8. Researchers at Agency for Science Technology and Research (ASTAR) Report Research in Immunoglobulins (Generating and characterizing a comprehensive panel of CHO cells glycosylation mutants for advancing glycobiology and biotechnology research).

9. Researchers Submit Patent Application, "Manufacturing Optimization Of Gl-2045, A Multimerizing Stradomer", for Approval (USPTO 20240279273).

10. Patent Application Titled "Composition and Method" Published Online (USPTO 20240262928).

11. Researchers Submit Patent Application, "Composition and Method", for Approval (USPTO 20240262925).

12. Data on Breast Cancer Described by Researchers at Volgograd State Medical University (Experimental in Vitro and in Vivo Studies of the Antitumor Activity of New Azoloazine Derivatives for the Treatment of Breast Cancer).

13. Boehringer Ingelheim Pharma GmbH & Co. KG Reports Findings in Biotechnology (Development of Responsive Promoters and their Utilization for Stable CHO Sensor Cell Lines).

14. Janus Mazebots and Cellbots Navigating Obstacles in Dense Mammalian Environment.

15. Study Findings from Mashhad University of Medical Sciences Advance Knowledge in Nanoparticles [Comparative Study on Biosynthesizing Selenium Nanoparticles by Gum Arabic and Poly Anionic Cellulose to Prevent Radiation-Induced Death in Chinese...].

16. Angiotensin-(1-5) is a Potent Endogenous Angiotensin AT2-Receptor Agonist.

17. "In Vitro Glycoengineering Of Antibodies" in Patent Application Approval Process (USPTO 20240101643).

18. Reports on Recombinant Proteins Findings from National Autonomous University of Mexico (UNAM) Provide New Insights (Expression In Cho Cells of a Bacterial Biosynthetic Pathway Producing a Small Non-ribosomal Peptide Aldehyde Prevents...).

19. Study Results from Xinxiang Medical University Broaden Understanding of Science and Technology (Synthetic enhancers including TFREs improve transgene expression in CHO cells).

20. "Compositions And Methods For Controlled Ovarian Stimulation" in Patent Application Approval Process (USPTO 20240033329).

21. Researcher at Kyushu University Discusses Research in Artificial Genes (High-Level Production of scFv-Fc Antibody Using an Artificial Promoter System with Transcriptional Positive Feedback Loop of Transactivator in CHO Cells).

22. Patent Issued for Manufacturing optimization of GL-2045, a multimerizing stradomer (USPTO 11795193).

23. Patent Issued for Method for in vitro glycoengineering of antibodies (USPTO 11767342).

24. Patent Issued for Nucleic acids encoding anti-OX40L antibodies (USPTO 11753479).

25. Chinese Academy of Agricultural Sciences Reports Findings in Antibodies (Expression of ASFV p17 in CHO cells and identification of one novel epitope using a monoclonal antibody).

26. Research on Gene Therapy Described by a Researcher at Slovak Academy of Sciences (Cost-Effective Protein Production in CHO Cells Following Polyethylenimine-Mediated Gene Delivery Showcased by the Production and Crystallization of Antibody Fabs).

27. Researcher at Leibniz University Hannover Targets Immunoglobulins (Establishment of a Perfusion Process with Antibody-Producing CHO Cells Using a 3D-Printed Microfluidic Spiral Separator with Web-Based Flow Control).

28. Zhejiang University Reports Findings in Biomarkers (H-1 Nmr-based Process Understanding and Biochemical Marker Identification Methodology for Monitoring Cho Cell Culture Process During Commercial-scale Manufacturing).

29. A Phase II, Single Center, Randomized, Blind, Controlled Clinical Trial to Evaluate the Immunogenicity and Safety of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 30 Years and Above.

31. Boehringer Ingelheim Pharma GmbH & Co. KG Reports Findings in Biotechnology (Deciphering integration loci of CHO manufacturing cell lines using long read nanopore sequencing).

32. A Single-center, Randomized, Double-blind, Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of Booster Vaccination of Recombinant Variant COVID-19 Vaccine (Sf9 Cell) in Healthy People Aged 18 Years and Older.

33. Findings from Tufts University in the Area of Monoclonal Antibodies Described (Rational Design of a Nivolumab-based Anti-pd-1 Single Chain Variable Fragment That Blocks the Interaction Between Pd-1 Expressed On T-cells and Pd-l1 On Cho Cells).

34. Study Results from Islamic Azad University Provide New Insights into COVID-19 (Antigenicity and immunogenicity of SARS-CoV-2 surface glycoprotein fragment in CHO cells).

36. Findings from University College Dublin Provide New Insights into Life Science (Automated Assembly of Hybrid Dynamic Models for Cho Cell Culture Processes).

37. Patent Issued for Cellular glycosaminoglycan compositions and methods of making and using (USPTO 11549000).

38. Prediction of N-linked glycan branching patterns using artificial neural networks

39. Breaking the ties that bind centriole numbers.

40. Two heads are better than one.

41. Hamster cells bring DBPs into the library.

42. Galsulfase.

43. Cell polarization mechanisms during directed cell migration.

44. Herpesvirus hijacks an integrin.

45. New lead found to a possible "insulin pill".

46. Antibodies directed against the ectodomain of ICA512: is there any evidence in patients with diabetes mellitus?

47. Express together and conquer.

Catalog

Books, media, physical & digital resources